Cross-Ancestry Analysis Identifies Shared Genetic Risk for Major Psychiatric Disorders

A Shared Blueprint for Psychiatric Disorders

Genome-wide association studies have become a cornerstone for elucidating the genetic underpinnings of complex, heritable conditions, from epilepsy to tic disorders [1, 2]. In clinical psychiatry, while the heritability of major disorders is well-recognized, the underlying biological architecture remains difficult to translate into diagnostic or therapeutic utility. This challenge is exacerbated by ancestral bias in genomic data, as findings from one population often fail to generalize to others [3]. Expanding these genetic investigations to include more diverse cohorts is therefore essential for a comprehensive understanding of disease biology [4]. A large-scale analysis now provides a detailed map of the genetic architecture shared among bipolar disorder, major depressive disorder, and schizophrenia, offering a cross-ancestry perspective on psychiatric risk.

Mapping the Cross-Ancestry Genetic Landscape

To better define the biological commonalities between major psychiatric conditions, the researchers conducted a multivariate genome-wide association study (GWAS), a statistical method that allows for the simultaneous analysis of multiple clinical traits to identify shared genetic variants. By integrating genetic data from both European and East Asian populations, the study aimed to uncover universal genetic underpinnings that remain consistent across diverse ancestral backgrounds. This cross-ancestry approach increases the statistical power to detect risk variants that might be missed in single-ancestry cohorts and ensures that the findings are applicable to a broader patient demographic. The analysis identified 403 genetic loci associated with a shared polygenic liability (the total genetic burden or cumulative risk contributed by many small-effect genetic variants across the genome) for bipolar disorder, major depressive disorder, and schizophrenia. These findings confirm that these three disorders share substantial genetic overlap, pointing toward common physiological mechanisms that transcend traditional diagnostic boundaries. Among the identified sites, the researchers highlighted 88 novel regions that were not previously associated with these conditions. This discovery of nearly 100 new genetic markers provides a more granular map of the inherited risk factors that contribute to the development of severe psychiatric illness across different global populations.

Pinpointing High-Confidence Candidate Genes

While identifying 403 risk loci is a significant step, these genomic regions can contain multiple genes, making it difficult to isolate the specific causal variants. To address this, the investigators employed cross-ancestry fine-mapping, a statistical technique used to pinpoint specific causal genetic variants within a broader genomic region. This analysis highlighted several robust shared signals, with a particularly strong association found at the VRK2 gene (rs7596038). The clinical importance of this finding is underscored by its consistency: the VRK2 signal was significant across both the European and East Asian cohorts, suggesting it represents a core biological risk factor that is not dependent on a specific ancestry. Moving from individual variants to functional genes, the researchers next applied gene prioritization (a computational method of ranking genes most likely to be involved in a disease based on their biological function and other data) to narrow the field to 90 high-confidence candidate genes. An analysis of these prioritized genes revealed that they were significantly enriched in neurodevelopmental pathways. This finding suggests that the shared genetic liability for schizophrenia, bipolar disorder, and major depressive disorder may be rooted in common biological processes that guide early brain formation and maturation, offering a potential etiological link between these distinct clinical diagnoses.

Cellular Contexts and Signaling Pathways

To move beyond identifying genes and toward understanding their functional impact, the researchers utilized single-nucleus RNA sequencing, a technology that examines gene expression in individual cells rather than bulk tissue. This high-resolution approach allowed the team to pinpoint the specific cellular environments where the shared genetic risk for bipolar disorder, major depressive disorder, and schizophrenia is most active. The analysis implicated excitatory neurons as a primary cellular context, suggesting that the genetic liability may disrupt the fundamental signaling that drives cortical activity. Furthermore, the study identified astrocytes (the non-neuronal cells responsible for maintaining the blood-brain barrier and supporting synaptic function) as key cellular contexts for these shared genetic risks. The investigation further clarified the biological mechanisms at play by identifying specific signaling pathways that are common across these psychiatric conditions. The findings emphasized the NCAM1-FGFR1 signaling pathway and the NEGR1-NEGR1 signaling pathway as shared biological mechanisms. These pathways are involved in cell adhesion and neuronal growth, providing a molecular link between the genetic findings and the structural brain alterations observed in patients. By identifying these specific molecular interactions, the results highlight potential therapeutic targets for psychiatric disorders that could lead to more precise interventions. Ultimately, the study underscores the critical importance of diverse ancestry studies in precision psychiatry, as including data from both European and East Asian populations ensures that these biological insights and future treatments are applicable to a global patient population.

Clinical Implications for Brain Structure and Risk Prediction

The researchers employed Mendelian randomization (a statistical method that uses genetic variants to determine if an association between an exposure and an outcome is likely causal) to investigate the physical consequences of the identified genetic risk. This analysis provided evidence linking the shared genetic liability for these psychiatric conditions to structural brain alterations in patients. These physical changes were specifically identified in brain regions crucial for emotion and cognition, suggesting that the inherited risk factors identified in the study manifest as measurable differences in the neural architecture responsible for mood regulation and executive function. To translate these genetic findings into potential clinical tools, the study authors derived polygenic risk scores, which are numerical estimates of an individual's total genetic risk for a condition based on their unique profile of genetic variants. These scores, calculated from the shared genetic liability across the studied conditions, substantially enhanced predictive accuracy for bipolar disorder and schizophrenia. Furthermore, the polygenic risk scores demonstrated strong trans-ancestry validity, performing consistently across both European and East Asian populations. This finding is particularly relevant for clinicians treating diverse patient populations, as it suggests that genetic risk models developed using cross-ancestry data may offer more equitable predictive utility than those based on a single ancestral group.

References

1. Strom NI, Halvorsen MW, Grove J, et al. Genome-Wide Association Study Meta-Analysis of 9619 Cases With Tic Disorders.. Biological psychiatry. 2025. doi:10.1016/j.biopsych.2024.07.025

2. Stevelink R, Campbell C, Chen S, et al. GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture. Nature Genetics. 2023. doi:10.1038/s41588-023-01485-w

3. Nievergelt CM, Maihofer AX, Klengel T, et al. International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci. Nature Communications. 2019. doi:10.1038/s41467-019-12576-w

4. Kurki M, Karjalainen J, Palta P, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023. doi:10.1038/s41586-022-05473-8